Autopsy report · NCT00944216

Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study

“terminated due to administrative reasons.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month after it had already started.
• Ran for about 7 months before it stopped.
• 1 participant enrolled.
• Results were posted on the registry 12 years 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Wright State University

Sponsor type

University, hospital or other

Conditions

Keratosis Pilaris

Interventions

Salkera Emollient Foam

Participants

1

Sites

1

Countries

United States

Trials that died the same way

• Ph 1B B-701 in Combination With Pembrolizumab in Metastatic Transitional Cell Carcinoma of the Urothelial Tract
  “Terminated due to safety concerns.” (86% match in meaning)
• Study to Determine the Utility of Wound Vacuum Assisted Closure (VAC) Compared to Conventional Saline Dressing Changes
  “terminated, due to lack enrollment,” (82% match in meaning)
• Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors
  “Terminated due to low accrual.” (82% match in meaning)
• Lafiya HIV-status Neutral Study - Protocol
  “terminated by the new administration” (81% match in meaning)
• Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer
  “Terminated due to withdrawal of support from our collaborator.” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.